Drug Discovery World

AUGUST 11, 2023

GenScript Biotech and T-MAXIMUM Biotech have formed a strategic collaboration to develop T-MAXIMUM’s CAR-T cell therapy using GenScript’s CRISPR nucleic acid reagents. GenScript will provide various CRISPR reagents to support the development of the universal CAR-T products from discovery to commercialisation.

Reagent 52

Reagent Development Gene Editing Production 52

The Pharma Data

OCTOBER 27, 2020

Food and Drug Administration (FDA). Clinical laboratories can process thousands of samples each day for less than $10 per sample running the assay on a single MassARRAY instrument, making it one of the highest throughput SARS-CoV-2 tests available under the Emergency Use Authorization program. SAN DIEGO , Oct. About Agena Bioscience.

Genetic Analysis 52

Genetic Analysis Genome Genomics Reagent 52

pharmaphorum

DECEMBER 16, 2022

Generative AI drug creation company Absci Corporation has added Dan Rabinovitsj (as pictured), VP of connectivity at Meta, to its Board of Directors. Optibrium, another software developer in the AI drug discovery space, has appointed Ian Smith as its new chief technology officer. AI and robotics hires. McKinnell, Jr.

Behavioural Health 52

Behavioural Health Reagent Gene Therapy Production 52

The Pharma Data

DECEMBER 23, 2020

In July, ViiV Healthcare, which is based in London, resubmitted the New Drug Application (NDA) for once-monthly dosing of cabotegravir and rilpivirine to the U.S. Food and Drug Administration (FDA), and further regulatory applications have been submitted and are being reviewed by other regulatory bodies worldwide, the company said.

Drugs 52

Drugs Licensing Licensing Vaccination 52

XTalks

AUGUST 18, 2020

SalivaDirect, a saliva-based COVID-19 test that was tested among players of the National Basketball Association (NBA), has been given emergency use authorization (EUA) by the US Food and Drug Administration (FDA). The EUA comes after Yale partnered with the NBA to study the efficacy of the saliva-based test.

FDA Approval 90

FDA Approval Reagent RNA Genome 90

Roots Analysis

AUGUST 28, 2022

Currently, several stakeholders are engaged in offering integrated solutions (platforms, software applications, services) to perform tissue analysis and spatial phenotyping, across the full continuum from discovery through translational and clinical research. Our Social Media Platform. Web: [link].

Genome 52

Genome Genomics RNA Genome Project 52

Advarra

NOVEMBER 29, 2022

However, despite the promise of these therapies, the regulations governing them lag the science, which in turn hinders the clinical translation of these novel medicines. The BGTC will act as a traffic light for these therapies, providing information on basic and clinical research, manufacturing, production, and regulatory requirements.

Gene Therapy 52

Gene Therapy Gene Production Clinical Trials 52